FDA panel backs Guerbet imaging agent

FDA's Medical Imaging Drugs Advisory Committee unanimously recommended approval of Dotarem gadoterate meglumine from Guerbet S.A. (Euronext:GBT) to detect and visualize areas with disruption of the bl...